Scientists test new combo aiming for HIV 'Drug Holiday'
NCT ID NCT05245292
Summary
This early-stage study is testing a new combination treatment for HIV. It involves two lab-made antibodies and an immune system booster. The goal is to see if this combo is safe and can control the virus well enough for participants to safely stop their daily antiviral pills for up to 72 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN IMMUNODEFICIENCY VIRUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Perelman School of Medicine University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
The Rockefeller University
New York, New York, 10065, United States
-
Weill Cornell Medicine, Cornell Clinical Trials Unit
New York, New York, 10021, United States
Conditions
Explore the condition pages connected to this study.